In vitro biological assessment of berberis vulgaris and its active constituent, berberine: antioxidants, anti-acetylcholinesterase, anti-diabetic and anticancer effects
Open Access
- 5 September 2013
- journal article
- Published by Springer Science and Business Media LLC in BMC Complementary and Alternative Medicine
- Vol. 13 (1), 218
- https://doi.org/10.1186/1472-6882-13-218
Abstract
Background: Berberis vulgaris is a well known plant with traditional herbal medical history. The aims of this study was to bioscreen and compare the in vitro biological activity (antioxidant, cholinergic, antidaibetic and the anticancer) of barberry crude extract and berberine active compound. Methods: The effect of B. vulgaris extract and berberine chloride on cellular thiobarbituric acid reactive species (TBARS) formation, diphenyle–α-picrylhydrazyl (DPPH) oxidation, cellular nitric oxide (NO) radical scavenging capability, superoxide dismutase (SOD), glutathione peroxidase (GPx), acetylcholinesterase (AChE) and α-gulcosidase activities were spectrophotometrically determined. On the other hand, the effect of extract and berberine as anticancer was estimated on three different cell lines which were MCF-7, HepG-2, and Caco-2 cells by using neutral red uptake assay which compared with control normal cells (PBMC). Results: Our results showed that barberry crude extract contains 0.6 mg berberine/mg crude extract. Barberry extract showed potent antioxidative capacity through decreasing TBARS, NO and the oxidation of DPPH that associated with GPx and SOD hyperactivation. Inhibitory effect of berberis crude extract on α-glucosidase was more potent than that of berberine chloride, while both had the same AChE inhibitory effect. Besides, different concentrations of both berberine chloride and barberry ethanolic extract showed to have no growth inhibitory effect on normal blood cells (PBMC). Otherwise, both berberine chloride and barberry ethanolic extract showed to have inhibitory effect on the growth of breast, liver and colon cancer cell lines (MCF7, HepG2 and CACO-2, respectively) at different incubation times starting from 24 hrs up to 72 hrs and the inhibitory effect increased with time in a dose dependant manner. Conclusion: This work demonstrates the potential of the barberry crude extract and its active alkaloid, berberine, on suppressing lipid peroxidation, suggesting a promising use in the treatment of hepatic oxidative stress, Alzheimer and idiopathic male factor infertility. Beside, berberis vulgaris ethanolic extract is safe non-toxic extract as it was not inhibit the growth of PBMC that can induce cancer cell death that could return to its powerful antioxidant activity.Keywords
This publication has 53 references indexed in Scilit:
- Anti-cancer natural products isolated from chinese medicinal herbsChinese Medicine, 2011
- Berberine modulates AP-1 activity to suppress HPV transcription and downstream signaling to induce growth arrest and apoptosis in cervical cancer cellsMolecular Cancer, 2011
- Crinum Latifolium Leave Extracts Suppress Immune Activation Cascades in Peripheral Blood Mononuclear Cells and Proliferation of Prostate Tumor CellsScientia Pharmaceutica, 2011
- Assessment of immune response to repeat stimulation with BCG vaccine using in vitro PBMC modelJournal of Immune Based Therapies and Vaccines, 2010
- Effect of different extraction protocols on anticancer and antioxidant activities of Berberis koreana bark extractsJournal of Bioscience and Bioengineering, 2009
- Pharmacological and therapeutic effects of Berberis vulgaris and its active constituent, berberinePhytotherapy Research, 2008
- Antioxidant and cytoprotective compounds from Berberis vulgaris (barberry)Phytotherapy Research, 2008
- Natural Products as Sources of New Drugs over the Period 1981−2002Journal of Natural Products, 2003
- Inhibition of Activator Protein 1 Activity by Berberine in Human Hepatoma CellsPlanta Medica, 1999
- Randomized Controlled Trial of Berberine Sulfate Therapy for Diarrhea Due to Enterotoxigenic Escherichia coli and Vibrio choleraeThe Journal of Infectious Diseases, 1987